Further exploration of the complex interplay between Ca2+ signaling, mitochondria dynamics, apoptosis, and mTOR hyperactivation will be required to improve our understanding on the pathophysiology of TSC and associated neuropsychiatric disorders and pave the way to potential targeted therapeutic interventions. This evidence concerns the gene MTOR and tuberous sclerosis.